Syncom Formulations (India) Ltd.

Financial

	Syncom Formulations	Beta Drugs	Bliss GVS Pharma
Operational Metrics
Financials
5 yr Average ROE	8.81 %	21.73 %	7.87 %
5yr average Equity Multiplier	1.5	1.75	1.33
5yr Average Asset Turnover Ratio	0.79	1.04	0.63
5yr Avg Net Profit Margin	7.78 %	11.97 %	9.44 %
Price to Book	5.91	0.0	1.5
P/E	40.88	43.07	18.68
5yr Avg Cash Conversion Cycle	84.02 Days	15.7 Days	169.17 Days
Inventory Days	27.61 Days	43.83 Days	51.37 Days
Days Receivable	123.89 Days	87.61 Days	187.07 Days
Days Payable	93.18 Days	113.94 Days	75.42 Days
5yr Average Interest Coverage Ratio	39.83	13.71	15.0
5yr Avg ROCE	12.74 %	27.85 %	14.67 %
5yr Avg Operating Profit Margin	9.47 %	21.58 %	17.43 %
5 yr average Debt to Equity	0.2	0.23	0.13
5yr CAGR Net Profit	19.56 %	31.07 %	-4.95 %
5yr Average Return on Assets	5.89 %	12.53 %	5.91 %
Shareholdings
Promoter Holding	50.57 %	66.73 %	35.29 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	4.45 %	0.02 %	2.15 %
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0

Business

	Syncom Formulations	Beta Drugs	Bliss GVS Pharma
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 97.31 Commodity 1.36 Rental Income 0.69 Manufacturing of Oncology medicines 0 Anti Inflammatory 0 Anti-biotic 0 Anti-bacterial 0 Anti-fungal, 0 Antimalarial 0 Others 0.64	Product Wise Break-Up Commodity 0 Anti-biotic 0 Anti-fungal, 0 Anti-bacterial 0 Anti Inflammatory 0 Pharmaceutical 0 Antimalarial 0 Rental Income 0 Oncology 100.0	Product Wise Break-Up Commodity 0 Antibiotics 5.0 Anti-fungal 16.0 Anti-bacterial 0 Anti Inflammatory 7.0 Pharmaceutical 0 Anti Malarials 43.0 Rental Income 0 Manufacturing of Oncology medicines 0 Others 29.0
Location Wise Break-Up	Location Wise Break-Up International 78.11 Domestic 21.89 Rest of the World 0 India 0	Location Wise Break-Up International 0 India 0 Rest of the World 0 India 83.33 Others 16.67	Location Wise Break-Up International 0 India 5.8 Rest of the World 94.2 Domestic 0
Drug Delivery Break-Up	Drug Delivery Break-Up Tablets 62.62 Injectables 17.99 Liquids 4.65 Capsules 4.18 Ointment 1.41 Dry Powder 0.59 Others 8.56	-	-
Capex	Capex Formulations 100.0 Trading of Commodities 0 Renting of Property 0	-	-
Operating Profit Break-Up	Operating Profit Break-Up Pharmaceutical Drugs & Formulations 95.53 Renting of Property 4.29 Trading of Commodities 0.18	-	-
Raw Material Break-Up	Raw Material Break-Up Packing Material 29.83 Paracetamol 7.39 CEFTRIAXONE SODIUM 2.61 Ibuprofen 2.19 Others 57.98	-	-
Asset Break-Up	Asset Break-Up Formulations 87.38 Renting of Property 11.54 Trading of Commodities 1.09	-	-

Syncom Formulations (India) Ltd.

Syncom Formulations (India) Ltd.

SIGN UP FOR FREE